Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2007 Dec;32(12):2727-36.
doi: 10.1016/j.addbeh.2007.04.006. Epub 2007 Apr 14.

Discrepancies between self-report and objective measures for stimulant drug use in HIV: cognitive, medication adherence and psychological correlates

M J Reinhard  1 , C H Hinkin, T R Barclay, A J Levine, S Marion, S A Castellon, D Longshore, T Newton, R S Durvasula, M N Lam, H Myers
Affiliations
Comparative Study

Discrepancies between self-report and objective measures for stimulant drug use in HIV: cognitive, medication adherence and psychological correlates

M J Reinhard et al. Addict Behav. 2007 Dec.

Abstract

While it has long been recognized that self-reported drug use may be at variance with objectively obtained evidence such as urine toxicology assays, few studies have explored the behavioral correlates of such discrepancies. Here we compared self-reported and objective measures of stimulant drug use for 162 HIV infected individuals and identified a sub-group with discrepancies between data obtained via the two methods. Results showed poorer neurocognitive performance (attention, learning/memory) and lower medication adherence rates for the discrepant group as compared to those who either acknowledged their drug use or accurately denied recent stimulant use. Using the Millon Clinical Multiaxial Inventory-III, it was also found that those in the discrepant group were more hesitant to reveal psychopathology. Comparisons of self-reported and objectively measured medication adherence data are also discussed.

PubMed Disclaimer

References

    1. Anglin MD, Longshore D, Turner S. Treatment alternatives to street crime: An evaluation of five programs. Criminal Justice and Behavior. 1999;26(2):168–195.
    1. Bangsberg D, Hecht F, Charlesbois E, Zolopa A, Holodniy M, et al. Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS. 2000;14:357–66. - PubMed
    1. Chang L, Ernst T, Speck O, Grob CS. Additive effects of HIV and chronic methamphetamine use on brain metabolite abnormalities. Am J Psychiatry. 2005;162:361–9. - PMC - PubMed
    1. Chermack ST, Roll J, Reilly M, Davis L, Kilaru U, Grabowski J. Comparison of patient self-reports and urinalysis results obtained under naturalistic methadonetreatment conditions. Drug & Alcohol Dependence. 2000;59(1):43–49. - PubMed
    1. Chesney M, Ickovics J, Chambers D, et al. Patient care committee and adherence working group of the outcomes committee of the Adult AIDS Clinical Trials Group (AACTG). Self-reported adherence to antiretroviral medication among participants in HIV clinical trials: the AACTG adherence instrument. AIDS Care. 2000;12:255–266. - PubMed

Publication types

Substances